Roger C. Lucas
Direktor/Vorstandsmitglied bei Printware LLC
Ursprung des Netzwerks ersten Grades von Roger C. Lucas
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 28 | |
| Subsidiary | Pharmaceuticals: Major | 26 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Roger C. Lucas
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| 3M COMPANY | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| RAYMOND JAMES FINANCIAL, INC. | Investment Managers | Private Equity Analyst | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| JANEL CORPORATION | Air Freight/Couriers | Director/Board Member Director/Board Member | |
| University of Notre Dame | College/University | Undergraduate Degree Undergraduate Degree | |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chairman Director/Board Member Corporate Officer/Principal | |
CyVek, Inc.
 CyVek, Inc. BiotechnologyHealth Technology CyVek, Inc. engages in the development of a novel, platform technology for measuring analytes in biological samples. It is a biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for performing multi-analyte immunoassays. The firm is a versatile platform that can be quickly and easily configured for diverse applications such as rapid diagnostic tests, multi-sample multi-analyte tests, or routine ELISA-like tests, for use in both research and clinical settings. The company offers an breadth of applications, from life science research to drug discovery, personalized medicine, diagnostics, and point-of-care testing. CyVek was founded by Per J. Hellsund, Rajiv Pandey and Marty Andrew Putnam in 2010 and is headquartered in Wallingford, CT. | Biotechnology | President President Director/Board Member Director of Finance/CFO | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree Corporate Officer/Principal | |
Bio-Techne
 Bio-Techne Medical SpecialtiesHealth Technology Bio-Techne is a life sciences company founded in 1981 that provides innovative tools and bioactive reagents for the research and clinical diagnostic communities. The company is based in Devens, MA. The company's products aid in scientific investigations into biological processes and the nature and progress of specific diseases, drug discovery efforts, and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $1.10 billion in net sales in fiscal 2023 and has approximately 3,200 employees worldwide. | Medical Specialties | President Director/Board Member | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member Human Resources Officer | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Indiana University | College/University | Masters Business Admin Undergraduate Degree | |
| Yale University | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| St. John's University | College/University | Undergraduate Degree Undergraduate Degree | |
| St. Mary's College of California | College/University | Masters Business Admin | |
| University of California, Berkeley | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree Doctorate Degree | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
| NEUROPACE, INC. | Medical Specialties | Director/Board Member | |
ProteinSimple
 ProteinSimple Medical SpecialtiesHealth Technology ProteinSimple engages in the proprietary systems and consumables for protein analysis. Its products include simple plex, ice, simple western, micro-flow imaging, and single-cell western. The company was founded by Linda Cahill, Nancy Allbritton, Christopher Sims, Scott Lockard, and Jim Schlater in December 2000 and is headquartered in San Jose, CA. | Medical Specialties | Chief Executive Officer Corporate Secretary Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Research & Diagnostic Systems, Inc.
 Research & Diagnostic Systems, Inc. Medical SpecialtiesHealth Technology Research & Diagnostic Systems, Inc. manufactures biological products. It biotechnology division products include antibodies, clinical diagnostic kits, DNA amplification, messenger RNA, cytokines and enzymes & many more. The firm’s hematology division sells blood components used to calibrate and test blood analysis equipment. The company was founded in 1976 and is headquartered in Minneapolis, MN. | Medical Specialties | President Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| THERMO FISHER SCIENTIFIC | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Human Resources Officer | |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
The Royal Netherlands Academy of Arts & Sciences
 The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Netherlands Academy of Arts & Sciences provides research services in the field of science and art. The private company is based in Amsterdam, Netherlands and has subsidiaries in Netherlands. The CEO of the Dutch company is Wilma de Koning. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| California Institute for Regenerative Medicine | General Government | Director/Board Member Director/Board Member | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor | |
Novus Biologicals LLC
 Novus Biologicals LLC Pharmaceuticals: MajorHealth Technology Novus Biologicals LLC develops and markets antibodies for scientific researchers in government, university, and biotech labs worldwide. It provides primary antibodies, secondary antibodies, antibody packs, lysates, peptides and proteins, antibody pairs, kits, RNAi, slides, isotype controls, support products, and various research reagents. Novus products are used in various research areas, including apoptosis, autophagy, cancer, DNA repair, epigenetics, epitope tags, GPCR, hypoxia, lipid and metabolism, loading controls, neuroscience, stem cell markers, cellular markers, immunology, and protein turnover. The company was founded by Karen M. Padgett in 1996 and is headquartered Littleton, CO. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
| Scripps Institution of Oceanography | College/University | Graduate Degree | |
| DNAX Research, Inc. | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | ||
| Accordia Global Health Foundation | Investment Trusts/Mutual Funds | Director/Board Member Chairman | |
| Stanford Graduate School of Business | College/University | Doctorate Degree Masters Business Admin Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
OrbiMed Private Investments VI LP
 OrbiMed Private Investments VI LP Investment ManagersFinance Orbimed Private Investments VI LP seeks investment opportunities companies located in North America and Europe. The fund targets companies operating in the fields of biopharmaceutical, medical device, diagnostics and healthcare services. It provides financing for seed stage, early stage, and later stage companies for both public and private companies with an investment size of $10 million to $75 million. | Investment Managers | Director/Board Member | |
B-MoGen Biotechnologies, Inc.
 B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology B-MoGen Biotechnologies, Inc. provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing. It offers custom vector generation services that include multi-gene expression vectors that are delivered via the proven sleeping beauty transposon system; and custom gene targeting vectors. The company was founded by David A. Largaespada and Branden S. Moriarity in 2015 and is headquartered in Minneapolis, MN. | Biotechnology | Director/Board Member Director/Board Member | |
| ARCUS BIOSCIENCES, INC. | Biotechnology | Founder Human Resources Officer Corporate Officer/Principal | |
Pionyr Immunotherapeutics, Inc.
 Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Pionyr Immunotherapeutics, Inc. develops cancer immunotherapies. It targets the tumor microenvironment to enhance the body?s antitumor immunity. The company was founded by Max Krummel and Sachdev Sidhu in 2015 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Charm Therapeutics Ltd.
 Charm Therapeutics Ltd. BiotechnologyHealth Technology Charm Therapeutics Ltd. is a British London-based company that is discovering and developing small molecule medicines using its proprietary 3D deep learning-enabled platform, Dragonfold. The company aims to create life-changing therapies for difficult-to-drug targets in cancer and other disease areas. Charm Therapeutics has raised $70 million to date and is supported by high-quality international investors, including Orbimed, F-Prime Capital, General Catalyst, Khosla Ventures, Bristol Myers Squibb, NVIDIA, and Grep-VC. The company was founded in 2021 by Laksh Aithani and David Baker, with Laksh Aithani serving as the CEO since then. | Biotechnology | Director/Board Member | |
| ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Aer Therapeutics, Inc.
 Aer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aer Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Raleigh, NC. The company's mission is to advance the treatment paradigm for mucus mediated lung diseases. The company is dedicated to delivering a therapeutic solution to patients suffering from muco-obstructive lung diseases, with their initial focus being on chronic obstructive pulmonary disease (COPD) and other muco-obstructive lung diseases to follow, including asthma, cystic fibrosis, and primary ciliary. The company was founded by John Fahy, and the CEO is Jim Shaffer. | Pharmaceuticals: Major | Director/Board Member | |
Bio-Techne Ltd.
 Bio-Techne Ltd. Miscellaneous Commercial ServicesCommercial Services Bio-Techne Ltd. engages in the provision of research and development systems and biotechnology products. The company was founded on April 6, 1990 and is headquartered in Abingdon, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member |
Statistik
International
| Vereinigte Staaten | 48 |
| Vereinigtes Königreich | 3 |
| Niederlande | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 13 |
| Finance | 5 |
| Commercial Services | 5 |
| Transportation | 2 |
Operativ
| Director/Board Member | 235 |
| Corporate Officer/Principal | 123 |
| Independent Dir/Board Member | 60 |
| Undergraduate Degree | 40 |
| Chairman | 38 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Henry McKinnell | 35 |
| Rishi Gupta | 29 |
| Edward Penhoet | 29 |
| Karen Holbrook | 23 |
| Joseph Feczko | 23 |
| Lowell E. Sears | 22 |
| Charles Kummeth | 21 |
| Randolph Steer | 19 |
| Sam Wertheimer | 17 |
| Jenny Rooke | 17 |
| James Tyree | 17 |
| Geoffrey Parker | 16 |
| Jan Hillson | 16 |
| Juan Jaen | 16 |
| William Fairey | 15 |
- Börse
- Insiders
- Roger C. Lucas
- Unternehmensverbindungen
